Related Experiment Videos
THE SUPERIORITY OF STEROID-OCCLUSIVE THERAPY FOR BROMODERMA
The British Journal of Dermatology
|March 1, 1964
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Doppler ultrasound accurately screens patients with appendicitis.
The American surgeon·1999
Osler's legacies to dermatologists.
International journal of dermatology·1998
Preclinical science course "preludes" taken by premedical students: do they provide a competitive advantage?
Academic medicine : journal of the Association of American Medical Colleges·1996
Color Doppler sonographic findings in renal vascular lesions.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·1991
Insights into Pathogenesis of Chronic Spontaneous Urticaria.
The British journal of dermatology·2026
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
The British journal of dermatology·2026
Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.
The British journal of dermatology·2026
Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.
The British journal of dermatology·2026
Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.
The British journal of dermatology·2026
Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus <i>Penicillium herquei</i>.
Journal of Asian natural products research·2026
The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.
Frontiers in behavioral neuroscience·2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.
Endocrine, metabolic & immune disorders drug targets·2026